Rami Komrokji, MD
Enriched profileProfessor; Vice Chair, Malignant Hematology Department; Section Head, Leukemia and MDS; Senior Member, Malignant Hematology and Experimental Therapeutics Program (also described as Clinical Director, Malignant Hematology Department, per AAMDSIF bio) · H. Lee Moffitt Cancer Center and Research Institute
Rami Komrokji is Professor; Vice Chair, Malignant Hematology Department; Section Head, Leukemia and MDS; Senior Member, Malignant Hematology and Experimental Therapeutics Program (also described as Clinical Director, Malignant Hematology Department, per AAMDSIF bio) at H. Lee Moffitt Cancer Center and Research Institute. OpenAlex indexes 1,527 publications with 19,045 citations (h-index 69); ClinicalTrials.gov lists 14 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Hematology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Rami S. Komrokji, M.D., is Professor at H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. The public record shows 1,527 publications with 19,045 citations (h-index 69), centered on Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments. It also documents an investigator role on 14 registered clinical trials, industry payments reported by 40 companies.
- Most recent indexed publication: 2026 · Blood
- Top research focus: Acute Myeloid Leukemia Research
- 14 registered trials on ClinicalTrials.gov
- Open Payments reporting from 40 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 97 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 330.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:
- BCL2i CLAG-M in R/R Acute Myeloid Leukemia
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
- Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
- Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Industry payments
Updated 27 Aug 2026
40 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- PharmaEssentia USA CorporationProgram year202525 payments$46,229openpaymentsdata.cms.gov ↗
- SOBI, INCProgram year202519 payments$32,895openpaymentsdata.cms.gov ↗
- Syndax Pharmaceuticals, Inc.Program year202514 payments$25,925openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
67.5%Kinase inhibitor15.9%Vanflyta54%Vonjo46%Part D<11 patientsNucleoside Metabolic Inhibitor12.6%Inqovi100%Part D≥11 patientsMusculoskeletal
13.2%Xanthine oxidase inhibitor13.2%Allopurinol100%Part D≥12 patientsNervous system
10.6%Opioid Agonist10.6%Oxycodone Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.
Journal of clinical oncology
Article2026
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/rami-komrokji-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/rami-komrokji-7b952047
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Rami-Komrokji
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/OncLive/videos/hear-rami-komrokji-md-of-moffitt-cancer-center-discuss-several-trials-that-suppo/1213350000430808
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Other
onclive.com/authors/rami-d-komrokji-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →iononline.com ↗
- Internship and Residency
Internal Medicine, Case Western Reserve University, St. Vincent Program, Cleveland, OH
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →iononline.com ↗ - Fellowship
Hematology/Oncology and Hematopoietic Stem Cell Transplantation, Strong Memorial Hospital, University of Rochester, Rochester, NY
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →iononline.com ↗ - Board certified
Hematology (Internal Medicine, Hematology taxonomy 207RH0000X, FL)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →npiregistry.cms.hhs.gov ↗
Editorial & leadership roles
journal and society appointments- Vice Chair
Malignant Hematology Department, Moffitt Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - Section Head
Leukemia and MDS, Moffitt Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - Senior Member
Malignant Hematology and Experimental Therapeutics Program, Moffitt Cancer Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →iononline.com ↗
Awards & honors
honors on the public record- King Hussein Cancer Award – Lifetime Achievement (International Track)
presented by Queen Rania Al Abdullah, November 14
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
Secondary affiliations
appointments beyond the home institution- Professor
Medicine & Oncologic Sciences, University of South Florida College of Medicine, Tampa, FL (joint academic appointment)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →patientpower.info ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bloodcancerstoday.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmc.ncbi.nlm.nih.gov ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vjhemonc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.